Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 957 results for "phase iii"

Novartis presents ground-breaking Phase III results showing AIN457 (secukinumab) significant efficacy in ankylosing spondylitis patients
AndhraNews.net

AstraZeneca and Amgen have announced positive results from a p...

AstraZeneca and Amgen have announced positive results from a phase III study of brodalumab in patients with moderate-to-sever plaque psoriasis. AstraZeneca and Amgen sai that AMAGINE-2, a pivotal, multi-arm phase III trial evaluating two ... Money Week, 8 hours ago
[x]  

165 images for phase iii

India TV, 1 day ago
India TV, 3 days ago
Bio Spectrum Asia, 5 hours ago
Jagran Post, 3 days ago
Times Union, 1 week ago
Pharma Letter, 6 days ago
Daily Times, 2 days ago
Proactive Investors.co.uk, 1 week ago
Pharma Letter, 1 week ago
Pharma Letter, 2 weeks ago

LG Jung signals go-ahead to Barapullah’s east-south link

Phase-III of the Barapullah elevated road, which will connect east and south Delhi, finally received the go-ahead on Tuesday from LG Najeeb Jung. NEW DELHI: Phase-III of the Barapullah elevated road, which will connect east and south Delhi, finally received ...
 Economic Times8 hours ago
Indian Express

Barapullah Phase-III in fast lane, work starts by March next year

Najeeb Jung Lt-Governor Najeeb Jung Tuesday approved the extension of the third phase of the Barapullah Elevated Road across the Yamuna. This phase will be from Sarai Kale Khan to Mayur Vihar and will be built at an estimated cost of Rs 1,260.63 ...
 Indian Express20 hours ago Extended Barapullah corridor to have walkways, cycle tracks  Business Standard1 day ago

Cardio3 BioSciences Announces the Nomination of Three Co-principal Investigators for its CHART-2 Phase III Clinical Trial of C-Cure® for the Treatment of Heart Failure

(C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today the appointment of its three Co-Principal Investigators for the CHART-2 study (Congestive ...
 Pettinga Financial Advisors9 hours ago 26/11/2014 - Cardio3 BioSciences announces the nomination of three Co-Principal Investigators for its CHART-2 phase III clinical trial of C-Cure® for the treatment of heart failure  Noodls8 hours ago CARDIO3 BIOSCIENCES : Announces the Nomination of Three Co-Principal Investigators for Its CHART-2 Phase III Clinical Trial of C-Cure® for the Treatment of Heart Failure  4 Traders9 hours ago CARDIO3 BIO : 26/11/2014 - Cardio3 BioSciences announces the nomination of three Co-Principal Investigators for its CHART-2 phase III clinical trial of C-Cure® for the treatment of heart failure  4 Traders8 hours ago
[x]  
India TV

Govt. keen on early expansion of phase III of FM radio

NEW DELHI: Even as the government wants to commence the expansion of phase III of FM radio to bring in additional revenue, there appears to be a re-think on the question permitting these channels to carry All India Radio news bulletins. While ...
 Indian Television2 days ago FM radio Phase III expansion may happen this fiscal: Jaitley  Hindu Business Line3 days ago Phase III expansion of FM radio likely this fiscal: Jaitley  India TV1 day ago Phase III expansion of FM radio this fiscal: Jaitley  Times of India1 day ago
[x]  

310 in fray for phase-III

s 310 candidates have been left in poll fray for phase-III of Assembly elections in Jharkhand whereas 50 nominations were made for phase-IV of the elections till Saturday . As many as 7 nominations have been rejected from constituencies under ...
 New Delhi Pioneer3 days ago

Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer

Comments LAWRENCEVILLE, N.J., Sept. 2, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that the first patient has been enrolled in its pivotal Phase III OPTIMA Study of ThermoDox® in ...
 AndhraNews.net5 days ago
Business Standard

Rotavirus trial starts in india

The vaccines unit of pharma giant Sanofi on Tuesday announced the start of Phase III clinical trial in India of its investigational rotavirus vaccine developed and manufactured by its affiliate Shantha Biotechnics. Sanofi Pasteur announced the trial, which ...
 Asian Age1 month ago Sanofi unit starts Phase 3 clinical trial of rotavirus vaccine  Business Standard1 month ago Sanofi launches phase-III trial for rotavirus vaccine  Business Standard1 month ago
Business Standard

Delhi Metro proposes over 103 km long corridor in phase IV

Even as work is underway on Metro's phase III, the Delhi Metro Rail Corporation has proposed 103.93 km long corridor in phase IV which is likely to come up by 2022. A Detail Project Report (DPR) for phase IV has been prepared and submitted to Delhi Government ...
 Business Standard1 month ago Metro submits project report for Ph IV  Times of India1 month ago
[x]  

FM radio auctions by Feb, says I&B minister

Auction for FM radio phase III will be completed by February 2015, a month before the current licences lapse, information and broadcasting (I&B) minister Prakash Javadekar assured on Wednesday.
 Times of India3 weeks ago Govt nixes Trai views on FM auction reserve price  Times of India2 months ago Government nixes TRAI views on FM radio auction reserve price  Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less